Michael Levinson is on record against 12 companies, each listed on its own site.
Michael Levinson is an early-stage investor whose portfolio of approximately fifty companies reflects a broad but discernible focus on technology-enabled services across health, media, enterprise software, and consumer experience. His backing of companies such as emocha Mobile Health, TowerView Health, Biomeme, Osmosis, SpeSo Health, Medlio, and Genoa Healthcare Telepsychiatry signals a sustained interest in digital health and health-technology innovation, spanning remote patient engagement, diagnostics, telepsychiatry, and medical education. Alongside this health orientation, Levinson has supported data and analytics ventures including Parse.ly, Cloudamize, Kwelia, and D8A Group, suggesting an appetite for businesses that help organizations extract actionable insight from complex information. His consumer-facing investments, which include SeatGeek, LevelUp, Brideside, Clothes Horse, and Fiestah, point to an interest in platforms that streamline purchasing, events, and lifestyle decisions. Levinson has also backed enterprise and marketing technology companies such as Adaptly, TrendKite, ConveyIQ, and Grassroots Unwired, rounding out a portfolio that spans both business-to-business and business-to-consumer models. The breadth of sectors represented, combined with the early and emerging nature of many of these ventures, suggests that Levinson operates as a generalist seed and early-stage investor who is drawn to technology-driven companies addressing friction in established industries, with particular recurring emphasis on health and wellness, data intelligence, and consumer commerce.